BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33843921)

  • 1. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):1-24. PubMed ID: 33843921
    [No Abstract]   [Full Text] [Related]  

  • 2. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Evens AM
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):20-23. PubMed ID: 33843922
    [No Abstract]   [Full Text] [Related]  

  • 3. Highlights in Hodgkin lymphoma from the 61st American Society of Hematology Annual Meeting.
    Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 6(2):1-24. PubMed ID: 33843909
    [No Abstract]   [Full Text] [Related]  

  • 4. Highlights in Hodgkin lymphoma from the 61st American Society of Hematology Annual Meeting: commentary.
    Straus DJ
    Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 6(2):20-23. PubMed ID: 33843910
    [No Abstract]   [Full Text] [Related]  

  • 5. Highlights in leukemia and lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 11(3):1-20. PubMed ID: 33843915
    [No Abstract]   [Full Text] [Related]  

  • 6. Highlights in leukemia and lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Barr PM
    Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 11(3):17-19. PubMed ID: 33843916
    [No Abstract]   [Full Text] [Related]  

  • 7. Highlights in relapsed/refractory follicular lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 2(1):1-20. PubMed ID: 33843857
    [No Abstract]   [Full Text] [Related]  

  • 8. Highlights in relapsed/refractory follicular lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Salles G
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 2(1):13-16. PubMed ID: 33843858
    [No Abstract]   [Full Text] [Related]  

  • 9. Highlights in myelodysplastic syndromes from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 5(1):1-24. PubMed ID: 33843865
    [No Abstract]   [Full Text] [Related]  

  • 10. Highlights in myelodysplastic syndromes from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Garcia-Manero G
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 5(1):20-23. PubMed ID: 33843866
    [No Abstract]   [Full Text] [Related]  

  • 11. Highlights in graft-vs-host disease from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 8(2):1-24. PubMed ID: 33843913
    [No Abstract]   [Full Text] [Related]  

  • 12. Highlights in CAR T-cell therapy from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 10(3):1-24. PubMed ID: 33843917
    [No Abstract]   [Full Text] [Related]  

  • 13. Highlights in CAR T-cell therapy from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Jacobson CA
    Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 10(3):19-23. PubMed ID: 33843918
    [No Abstract]   [Full Text] [Related]  

  • 14. Highlights in chronic graft-vs-host disease from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    DiPersio JF
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 8(2):20-23. PubMed ID: 33843914
    [No Abstract]   [Full Text] [Related]  

  • 15. Highlights in chronic lymphocytic leukemia from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 4(1):1-24. PubMed ID: 33843887
    [No Abstract]   [Full Text] [Related]  

  • 16. Highlights in chronic lymphocytic leukemia from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Davids MS
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 4(1):21-23. PubMed ID: 33843888
    [No Abstract]   [Full Text] [Related]  

  • 17. Highlights in chronic lymphocytic leukemia from the 61st American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2020 Jan; 18 Suppl 3(1):1-20. PubMed ID: 33843855
    [No Abstract]   [Full Text] [Related]  

  • 18. Highlights in chronic lymphocytic leukemia from the 61st American Society of Hematology Annual Meeting and Exposition: commentary.
    Awan FT
    Clin Adv Hematol Oncol; 2020 Jan; 18 Suppl 3(1):14-17. PubMed ID: 33843856
    [No Abstract]   [Full Text] [Related]  

  • 19. Meeting highlights 46th annual meeting of the American Society of Hematology December 2004 San Diego, California.
    Price N; Reddy GK; Jain VK
    Clin Lymphoma; 2004 Dec; 5(3):144-8. PubMed ID: 15636687
    [No Abstract]   [Full Text] [Related]  

  • 20. 42nd Annual Meeting of American Society of Hematology. San Francisco, CA. December 1-5, 2000.
    D'Orazio AI; Gambill BD
    Clin Lymphoma; 2001 Mar; 1(4):251-6. PubMed ID: 11715982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.